Citation Impact
Citing Papers
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
2013 StandoutScience
Colorectal cancer statistics, 2020
2020 Standout
Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis
2014
Colorectal cancer statistics, 2023
2023 Standout
Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics
2011
Rapid and selective detection of fatty acylated proteins using ω-alkynyl-fatty acids and click chemistry
2009 StandoutNobel
Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001–2020)
2020
Cancer treatment and survivorship statistics, 2022
2022 Standout
Breast cancer statistics, 2019
2019 Standout
Altered baroreflex responses in α7 deficient mice
2000
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
2016
A view on drug resistance in cancer
2019 StandoutNature
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Mechanism and medical implications of mammalian autophagy
2018 Standout
Mechanisms of hepatic stellate cell activation
2017 Standout
Diversity of vertebrate nicotinic acetylcholine receptors
2008
Descending control of pain
2002 Standout
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
2020 Standout
Burden of liver diseases in the world
2018 Standout
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
2002 StandoutNature
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
2017
Macrophages in immunoregulation and therapeutics
2023 Standout
Pathogenesis of Nonalcoholic Steatohepatitis
2016
MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression
2016
Complementary and Integrative Treatments
2013
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
2017
Colorectal cancer
2019 Standout
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
2016
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Advances in the treatment of neurofibromatosis-associated tumours
2013
Pyroptosis: mechanisms and diseases
2021 Standout
Inefficient cell-surface expression of hybrid complexes formed by the co-assembly of neuronal nicotinic acetylcholine receptor and serotonin receptor subunits
2001
Two functionally distinct α2-adrenergic receptors regulate sympathetic neurotransmission
1999 StandoutNatureNobel
A Role for cAMP in Long-Term Depression at Hippocampal Mossy Fiber Synapses
1998 StandoutNobel
Histology-agnostic drug development — considering issues beyond the tissue
2020
Current and future biomarkers in colorectal cancer
2017
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Hepatic expression of Sonic Hedgehog induces liver fibrosis and promotes hepatocarcinogenesis in a transgenic mouse model
2015
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
2005 Standout
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2020 Standout
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
2017 Standout
HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers
2018
Synthesis of Selective Agonists for the α7 Nicotinic Acetylcholine Receptor with In Situ Click-Chemistry on Acetylcholine-Binding Protein Templates
2012 StandoutNobel
Principles of Liver Regeneration and Growth Homeostasis
2012
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
2011
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
2020
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
2007
Hedgehog signaling in the liver
2010
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
2016
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
2007 Standout
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
2001 StandoutNature
Smoothened is a master regulator of adult liver repair
2013
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice
2013
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
2018 Standout
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
2012
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease
2018
Breast Cancer Statistics, 2022
2022 Standout
Neuronal α-Bungarotoxin Receptors Are α7 Subunit Homomers
2000
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?
2012
Short-Term Synaptic Plasticity
2002 Standout
In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease
2017 StandoutNobel
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
2015
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis
2014
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
2014
Cancer treatment and survivorship statistics, 2019
2019 Standout
Labeling and quantifying sites of protein palmitoylation
2004
PRESYNAPTIC RECEPTORS
1998
Nonalcoholic fatty liver disease
2015
Formation of the Nicotinic Acetylcholine Receptor Binding Sites
1998
Wound healing - A literature review
2016 Standout
Works of Fatima Rangwala being referenced
Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer
2017
Gastrointestinal symptoms in cancer patients with advanced disease
2012
Increased production of sonic hedgehog by ballooned hepatocytes
2011
Understanding the mechanisms of action of antiangiogenic agents in metastatic colorectal cancer: A clinician’s perspective
2014
Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1
2011
Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
2011
RARE-09. EFFICACY AND SAFETY OF DABRAFENIB + TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG)
2018
Neuronal α-Bungarotoxin Receptors Differ Structurally from Other Nicotinic Acetylcholine Receptors
1997
Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E–mutated (BRAFm) metastatic colorectal cancer (mCRC)
2016
Cancer Stem Cells: Repair Gone Awry?
2010
Updated efficacy of the MEK inhibitor trametinib (T), BRAF inhibitor dabrafenib (D), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E mutated (BRAFm) metastatic colorectal cancer (mCRC).
2015